My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2016
GLOBAL HEALTH POLICY
AIDS, Global Antimicrobial Resistance, Zika: IDSA Global Health Covers the Latest
Report on 21st International AIDS Conference 
 
The 21st International AIDS Conference returned to Durban South Africa in July 2016 to recognize progress made in the 16 years since the world began to recognize the enormity of the global HIV crisis, but also to confront continuing challenges. In August, IDSA Center for Global Health Policy released AIDS 2016 Progress and Challenge (PDF), a report from the ground, summarizing the conference, and highlighting developments and challenges in HIV and tuberculosis research, treatment, prevention, and funding.
 
Global Antimicrobial Resistance—Solutions to a Worldwide Threat

Starting with the beginning of the antimicrobial age, when new medicines opened the era of modern medicine, through the peak years of new antibiotic drug development in the 1970s when physicians were said to have “an embarrassment of choices,” to the threats posed today, Global Antimicrobial Resistance (PDF), a new white paper released in advance of the United Nations high level meeting on antimicrobial resistance, tells the story of the issues and solutions to a worldwide threat.
 
Science Speaks Covers Zika Research and Funding Developments 
 
The Center for Global Health Policy’s Science Speaks blog followed policy makers and scientists responding to the spread of Zika and its impacts with posts on: 
 
An update to World Health Organization guidelines reflecting discoveries of how, and for how long after infection the virus may be transmitted sexually . . . while a bill to fund responses to the Zika outbreak stalled again in Congress. 
 
A study review confirming that Zika is a trigger for Guillain Barre Syndrome, and a cause of microcephaly and other neurological disorders. 
 
Concerns from medical provider organizations and agencies that lack of funding will stall new Zika responses.


< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
HCV Guidance Panel Recommends Assessment for HBV Prior to Treatment
FDA Issues Ban on Triclosan, CDC Continues to Provide Guidance Throughout Zika Outbreak
CLINICAL PRACTICE MANAGEMENT
Medicare Will Soon Require More Coding Specificity on Claims
POLICY AND ADVOCACY
Advocacy for New Antibiotics and Policies to Combat AMR Continues
Helping Lawmakers Understand the Importance of LDTs and Risks of Proposed Regs
Join HIVMA for Updates on the Ryan White Program at IDWeek 2016
GLOBAL HEALTH POLICY
AIDS, Global Antimicrobial Resistance, Zika: IDSA Global Health Covers the Latest
EDUCATION AND RESOURCES
OFID Podcast Explores Root Causes of Decline in ID Fellowship Applicants
IDSA Education and Research Foundation: Steering Medical Students Toward ID
Consumer Reports Publishes HIVMA’s Choosing Wisely Resource on CD4 Testing
Interested in Influenza Vaccine Delivery? Earn CMEs by Using a New Physician Resource from NFID and ICID
YOU AND YOUR COLLEAGUES
In Memoriam: D.A. Henderson, MD, MPH
In Memoriam: Lenae Fountain-Moss
In Memoriam: Leland F. Powers
Member Report
FROM THE PRESIDENT
Be Part of the Solution at IDWeek Town Hall
TOP STORIES
IDSA’s Long-Standing Priorities Reflected in UN Declaration for Fighting AMR
Countdown to IDWeek 2016
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.